5 . 4 ± 3.1 3.9 ± 1.4 26.3 ± 5.9 -eTAM 2.5 ± 1* 1.3 ± 0.9*** 0.7 ± 0.7 7 ± 2.3* 73% Oral Control 12.2 ± 3.4 5.8 ± 1.9 1.8 ± 0.7 32 ± 6.4 -eTAM 6.7 ± 1.9** 0.9 ± 1**** 0 . 5± 0.6 14.7 ± 3.5* 5 4 % Significant reduction when compared with control group, p < 0.05 *p < 0.001 **p = 0.0012 ***p = 0.021 ****p = 0.0051
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Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. 18.4 ± 5.1 4 ± 1.7 1521 ± 339 -cTAM 13 ± 6.9* 66 ± 9.6* 13.6 ± 4.5 181 ± 91* 88% *Significant reduction when compared with control group, p < 0.0001
